Recent commentary around Grand Canyon Education (LOPE) has focused on modest student growth, stagnant earnings, and analyst caution. Together, these factors have kept sentiment muted and raised fresh ...
IBRX stock surge has pushed valuation to ~33x sales as Anktiva adoption accelerates - but the premium assumes flawless commercialization and expansion.